A Northwestern Medicine study has revealed a previously unknown connection between two fundamental cellular processes, ...
SAB Biotherapeutics’ DiversitAb novel drug development platform creates targeted fully human multi-epitope binding immunoglobulins (polyclonal antibodies) without the need for human donors. Its ...